~~<i id='1FD37CBF43'><strike id='1FD37CBF43'><tt id='1FD37CBF43'><pre id='1FD37CBF43'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：Wikipedia 2025-09-30 00:35:21 - browse：18

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Review: 'Barbie' will hit you like a shot in the heart

hotspot

leisure time

knowledge

entertainment

focus

AdobeYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followingtheflowofmoneyinmed

WSS

As Taiwan prepares for anti

Young boy dies in trial for Pfizer Duchenne gene therapy

FDA official pushes for dedicated emerging pathogens team

Scientific mystery highlights the blind spots in genomics databases

A double vaccine crisis is endangering millions of children

focus

comprehensive

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Multiple sclerosis has subtypes with different best treatments: study

How to save PrEP access — and even expand it

Gut bacteria may contribute to kidney autoimmunity, study finds

Walensky prepares to leave CDC — and Congress — behind

FDA official pushes for dedicated emerging pathogens team

Tori Bowie and the unacceptable rates of Black maternal death

CDC backtracks, saying fully vaccinated people can go maskless indoors

Continuity nursing helped my family in our darkest PICU moments

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

leisure time

As Taiwan prepares for anti

Researchers test human milk's ability to repair gut microbiome

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Providers still hesitate to prescribe buprenorphine, study finds

Drug companies' payments and gifts affect physicians' prescribing

Review: 'Barbie' will hit you like a shot in the heart

leisure time

knowledge

entertainment

focus